Articles published by Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 17, 2026
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results
November 12, 2026
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results
November 03, 2026
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
September 03, 2026
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
August 04, 2026
Via Business Wire
Tickers
ARWR
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 03, 2026
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR
Via Business Wire
Tickers
ARWR